QUIDELORTHO CORP (QDEL:NASDAQ)
$12.91 -1 (-7.1891%)
Analysed QUIDELORTHO CORP (QDEL:NASDAQ) News Sources
1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm
26-08-2026
yahoo.com
The 5 Most Interesting Analyst Questions From QuidelOrtho’s Q2 Earnings Call
15-08-2026
yahoo.com
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers
17-08-2026
yahoo.com
Faster Answers, Better Decisions: ADLM 2026 Highlights
27-08-2026
yahoo.com
Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players
16-09-2026
yahoo.com
Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment
24-09-2026
yahoo.com
2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges
25-09-2026
yahoo.com
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
07-10-2026
yahoo.com
QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q2 Earnings?
12-10-2026
yahoo.com
Reasons to Add QuidelOrtho Stock to Your Portfolio for Now
14-10-2026
yahoo.com
What is the current price of QUIDELORTHO CORP (QDEL:NASDAQ)?
The current price of QUIDELORTHO CORP (QDEL:NASDAQ) is $12.91.
QUIDELORTHO CORP (QDEL:NASDAQ) absolute price change since previous trading day?
The absolute price change of QUIDELORTHO CORP (QDEL:NASDAQ) since the previous trading day is $-1.
QUIDELORTHO CORP (QDEL:NASDAQ) percentage price change since previous trading day?
The percentage price change of QUIDELORTHO CORP (QDEL:NASDAQ) since the previous trading day is -7.1891%.
What is the most recent average sentiment score for QUIDELORTHO CORP (QDEL:NASDAQ)?
The most recent average sentiment score for QUIDELORTHO CORP (QDEL:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for QUIDELORTHO CORP (QDEL:NASDAQ)?
The most recent sentiment for QUIDELORTHO CORP (QDEL:NASDAQ) is .
SEC-8K** Filing Available For QUIDELORTHO CORP (QDEL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.